The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

CL/SAST/26-27/00709 Date: July 28, 2026 1) National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai – 400051. 2) BSE Limited Floor 25, P. J. Towers, Dalal Street, Mumbai, Mumbai – 400001. 3) Medplus Health Services Limited H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad - 500037, Telangana, India Dear Sir / Madam, Sub.: Disclosure under Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations 2011 in relation to creation of pledge over certain equity shares of Medplus Health Services Limited Pursuant to the disclosure required to be made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find attached the disclosure in respect of the pledged equity shares of Medplus Health Services Limited (“Target Company”) in favour of Catalyst Trusteeship Limited in the capacity of Debenture Trustee for the benefit of Debenture holders. This is for your information and records. Sincerely, For Catalyst Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Encl.: As above ANNEXURE A Format for disclosures under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1 Name of the Target Company (TC) MedPlus Health Services Limited Name(s) of the acquirer and Persons Acting in Catalyst Trusteeship Limited acting as Debenture Concert (PAC) with the acquirer Trustee on behalf of Debenture holders Whether the acquirer belongs to 3 No Promoter/Promoter group Name(s) of the Stock Exchange(s) where the BSE Limited and National Stock Exchange of shares of TC are Listed India Limited % w.r.t. total % w.r.t. total share/voting diluted 5 Details of the acquisition/disposal as follows Number capital share/voting wherever capital of applicable (*) the TC (**) Before the acquisition under consideration, holding of: a) Shares carrying voting rights - - - b) Shares in the nature of encumbrance 1,58,50,400 13.19 13.18 (pledge/lien/non-disposal undertaking/others) c) Voting rights (VR) otherwise than by shares - - - d) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 1,58,50,400 13.19 13.18 Details of acquisition / sale a) Shares carrying voting rights acquired / sold - - - b) VRs acquired / sold otherwise than by shares - - - c) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired / sold d) Shares Pledged/ encumbered/ invoked/ 49,00,000 4.08 4.08 released by the acquirer e) Total (a+b+c+/-d) 49,00,000 4.08 4.08 After the acquisition/sale, holding of: a) Shares carrying voting rights - - - b) Shares encumbered with the acquirer 2,07,50,400 17.27 17.26 c) VRs otherwise than by shares - - - d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive - - - shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total (a+b+c+d) 2,07,50,400 17.27 17.26 Mode of acquisition By way of creation of pledge over shares Date of acquisition/ disposal / sale of shares /VR or date of receipt of intimation of allotment June 24, 2026 of shares, whichever is applicable. Rs. 24,02,74,122 (12,01,37,061 Equity shares Equity share capital/total voting capital of the having face value of Rs 2 each) TC before the said acquisition/ disposal/ sale Rs. 24,02,74,122 (12,01,37,061 Equity shares Equity share capital/ total voting capital of the having face value of Rs 2 each) TC after the said acquisition/ disposal/ sale Rs. 24,04,75,502 (12,02,37,751 Equity shares Total diluted share/voting capital of the TC having face value of Rs 2 each) after the said acquisition/ disposal Note: (*) Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Signature of the acquirer / seller / Authorised Signatory For Catalyst Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Date: July 28, 2026